AF, "BMY spokesperson told me this morning that GILD rejected an offer to further develop daclatasvir and GS-7977 in Ph3"
Any data on GILD's internal NS5? If that stumbles, theyd be in a bit of trouble since one could imagine the 7977+Daclatasvir data bodes well for an INX189+Daclatasvir combo...